CSM Corbion NV

Corbion full year 2019 results

Corbion full year 2019 results



Corbion reported net sales of € 976.4 million in 2019. Organic net sales growth was 2.5% for

the year. Adjusted EBITDA in 2019 increased organically by 7.8% to € 145.9 million. These results are in line with the earlier management update of 29 January 2020. The company proposes to distribute a regular dividend of € 0.56 per share.

Olivier Rigaud, CEO, commented: “Looking back at 2019, I am pleased with the strong fourth quarter as we saw a further acceleration of organic growth. These results are in line with the earlier management update of 29 January 2020. Our FY 2019 results exceeded our management guidance of October 2019 for Ingredient Solutions, while Innovation Platforms performed as expected. Today we are excited to present our Advance 2025 strategy which talks about our vision for the Corbion future including the outlook for 2020.”

Key financial highlights FY 2019:

  • Net sales organic growth was 2.5%; volume growth was 3.4%
  • Adjusted EBITDA was € 145.9 million (FY 2018: € 131.6 million), an organic increase of 7.8% (including 6.1% positive effect from IFRS 16 implementation)
  • Adjusted EBITDA margin was 14.9% (FY 2018: 14.7%)
  • Adjustments at EBITDA level of € +18.4 million
  • Impairment of € 41.4 million related to our Algae business
  • Operating result was € 61.3 million (FY 2018: 87.9 million)
  • Free cash flow was € 9.6 million (FY 2018: € 11.9 million); the decline is mostly due to the acquisition of Granotec do Brazil (25 April 2019)
  • Net debt/EBITDA at year-end was 2.0x (year-end 2018: 1.6x)



Attachment

EN
09/03/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Corbion NV

Guy Sips ... (+11)
  • Guy Sips
  • Jacob Mekhael
  • Kristof Samoy
  • Livio Luyten
  • Lynn Hautekeete
  • Mathijs Geerts Danau
  • Michiel Declercq
  • Thibault Leneeuw
  • Thomas Couvreur
  • Wim Hoste
  • Wim Lewi

Dynamic Top Pick List How to start 2026?

How to start 2026? We have selected for the KBC Securities Dynamic Top Pick List 12 large-cap companies — AB InBev, Aedifica, Argenx, ASMi, Azelis, DEME, D'Ieteren, Shurgard, Sofina, Vopak, WDP, and Wolters Kluwer — along with 3 small and mid-cap names (under €1.5bn in market capitalization): Corbion, EVS, and IBA. So, going into 2026, we maintain a balanced approach in our Dynamic Top Pick List, featuring 8 cyclical and 6 defensive stocks, with a particular emphasis on value stocks that have b...

Hilde Van Boxstael ... (+4)
  • Hilde Van Boxstael
  • Livio Luyten
  • Thomas Couvreur
  • Wim Hoste
Wim Hoste
  • Wim Hoste

Corbion Strategy update shows increased focus, upgrade to BUY

Corbion's BRIGHT 2030 strategy update revealed an increasing focus on clean label Food Ingredients, Nutrition and Biomedical Polymers/Pharma. Biochemicals are being de-prioritized and the strategic ownership review on PLA will most likely result in an exit. Financial targets include a 3-6% annual organic sales growth target and a c 2pp increase in the adjusted EBITDA margin by 2028. A disciplined approach on capex is expected to result in an average 8% FCF yield in the coming years with a streng...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch